Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
MQB Partners is a global healthtech investment management firm based in Wellington, New Zealand. Founded by experienced entrepreneurs and investors in the healthcare and technology sectors, the firm focuses on originating, investing in, and managing healthtech investments for their clients. The firm has established itself as a key player in the healthtech investment space, emphasizing innovations that can significantly impact patient care and outcomes.
Currently, MQB Partners operates with a small but experienced team, which allows them to maintain a focused approach to their investments. The firm has a portfolio count of two notable companies and is actively seeking to expand its reach within the healthtech sector. Their global operations enable them to identify and support transformative healthtech solutions, particularly in the areas of devices and biopharma.
MQB Partners has achieved notable milestones since its inception, including participation in significant funding rounds for its portfolio companies. The firm’s commitment to advancing healthtech innovations positions it as a valuable partner for startups looking to scale in this competitive landscape.
MQB Partners invests primarily in the healthtech sector, which encompasses a wide range of areas including gene therapy, molecular medicine, neuroscience, biochemistry, digital health, medical devices, biotechnology, surgery, and clinical practice. Their investment strategy is informed by the practical experience of their team in healthcare and technology, allowing them to identify promising opportunities in later-stage and growth healthtech companies.
The firm targets investments in Series B and growth equity stages, focusing on companies that demonstrate potential for significant impact in patient care. MQB Partners emphasizes a global operational reach, which enables them to support innovative healthtech solutions across various geographic markets. They look for founders who possess a strong understanding of their respective fields and who are committed to advancing healthcare through technology.
MQB Partners has a focused portfolio that includes two notable companies:
Marko Bogoievski - Partner. Marko has extensive investment management experience, having previously served as CEO of Infratil and Infrastructure Investment Manager H.R.L. Morrison & Co., where he grew funds under management from $2.1B to $25B. His background spans finance, sales, investment management, and public-company governance.
Caroline Quay - Managing Partner. Caroline is a healthtech investor with over 20 years of experience in high-growth public and private healthtech companies. She has held roles such as Global General Counsel at Fisher & Paykel Healthcare and has founding executive experience at Aroa Biosurgery, which listed on the ASX in 2020.
Dr. Scott McPhee - Partner. Scott is an entrepreneurial scientist with over 20 years of experience in developing novel medicines. His previous roles include VP Clinical Development at Asklepios BioPharmaceutical and co-founder of Chatham Therapeutics, which was acquired by Baxter Healthcare.
Dr. Ken Chin - Partner. Ken is a medical doctor and healthcare-services entrepreneur with more than 20 years of experience. He has co-founded or owned healthcare services and consultancy businesses and has provided clinical insight into early-stage healthcare investments since 2016.
To pitch MQB Partners, founders should reach out through a warm introduction if possible. A well-prepared pitch deck should include details about the business model, market opportunity, and team qualifications. While there is no formal application process mentioned, a clear and concise presentation of the startup's value proposition is essential.
Response times may vary, but founders should expect to engage in follow-up discussions if initial interest is shown. Providing a comprehensive overview of the startup's potential impact on healthtech will enhance the chances of a favorable response.
On April 25, 2024, MQB Partners participated as a new investor in Cerevance's $47M Series B-1 extension, aimed at advancing clinical-stage CNS therapeutics. This investment highlights MQB's commitment to supporting innovative healthtech solutions.
As of now, there have been no other recent announcements or investments made public by MQB Partners since this funding round.
What are MQB Partners' investment criteria?
MQB Partners focuses on later-stage and growth healthtech companies, particularly in sectors such as gene therapy, molecular medicine, neuroscience, medical devices, and digital health. They seek companies that demonstrate potential for significant impact on patient care and outcomes.
How can I pitch to MQB Partners?
Founders interested in pitching to MQB Partners should prepare a comprehensive deck that outlines their business model, market opportunity, and team expertise. A warm introduction is preferred, but cold outreach may also be considered.
What makes MQB Partners different from other investors?
MQB Partners distinguishes itself through its deep expertise in healthcare and technology, as well as its global operational reach. The firm emphasizes practical experience in healthtech, which informs their investment decisions and support for portfolio companies.
What is the geographic scope of MQB Partners' investments?
MQB Partners operates on a global scale, with a particular focus on healthtech opportunities in New Zealand, the United States, and other international markets.
What is the typical check size for investments?
While specific check sizes are not disclosed, MQB Partners primarily invests in Series B and growth equity rounds, which typically involve larger capital commitments to support scaling companies.
What kind of post-investment support does MQB Partners provide?
The firm adds value to its portfolio companies through strategic guidance, access to a network of industry contacts, and operational support, leveraging the diverse backgrounds of its team members.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.